The FDA’s Peptide Vote Could Create Telehealth’s Next Multibillion Dollar Market The biotech industry is abuzz with excitement over the potential approval of peptides, tiny protein fragments touted for their supposed health benefits.
However, as the FDA's compounding advisory committee prepares to weigh in on the matter, it's worth examining the risks associated with this trend.
Peptides are essentially the latest darling of the wellness crowd, injected into the body and promising faster recovery, improved energy, and anti aging benefits.